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A B S T R A C T
Background: Both Transthoracic Echocardiography (TTE) and Transesophgeal 
Echocardiography (TEE) are effective investigation tools to detect cardioaortic sources 
of embolism in ischemic stroke. Nevertheless, there are still uncertainties about the cost-
effectiveness of these methods in non-selected patients with acute stroke.
Objectives: This study aimed to investigate the cost-effectiveness of TTE and TEE using 
a decision analytic model in non-selected patients with acute ischemic stroke with or 
without clinical and radiological signs of embolic pattern.
Patients and Methods: This cross-sectional cost-effectiveness study was performed in 
Nemazee hospital affiliated to Shiraz University of Medical Sciences from January 2014 
to April 2014. TTE and TEE were performed for all 65 consecutive patients with ischemic 
stroke (51.3% male, mean age of 69.7 ± 17.9 years). The required data were direct costs 
related to performance of TTE and TEE, which were obtained from the patients’ bills in 
their charts. A decision analytic model was implemented to assess the cost-effectiveness of 
these two methods, which demonstrated an Incremental Cost-Ef-fectiveness Ratio (ICER). 
Effectiveness was determined based on the number of disorders diagnosed using each of the 
two echoes confirmed by two cardiologists. All analyses were done using Tree Age Pro 2011.
Results: The results showed that TEE was more expensive than TTE in non-selected 
patients. Performing TEE increased the cost by 1494 USD and the effectiveness by 7%. As 
per ICER equation, for each increment unit in the effectiveness, performing TEE would 
increase the cost by 213.4 USD compared to TTE. TEE was cost-effective in comparison 
to TTE regardless of age factor considering the cutoff of Gross Domestic Product (GDP) 
by three for ICER. Moreover, TTE was cost-effective in 41-60- and 61-80-year-old age 
groups, while TEE was cost-effective in the 41-60-year-old age group. However, none of 
the techniques was cost-effective in patients above 81 years old.
Conclusions: The results of this study can help reduce the unnecessary use of 
echocardiography by considering the age group and their corresponding risk factors for 
developing ischemic stroke.
*Corresponding author: Afshin Borhani Haghighi, Department of Neurology, 
Nemazee Hospital, Shiraz, Iran. Tel/Fax: +98-7116272287, 
E-mail: neuro.ab@gmail.com.
1. Background
Cerebrovascular diseases are among the most common 
causes of mortality and morbidity particularly in developing 
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countries (1). Ischemic stroke is the most common cause of 
cerebrovascular diseases (2). At least one out of every four 
patients with ischemic stroke had a cardioembolic source 
in our previous series (3).
Both Transthoracic Echocardiography (TTE) and 
Transesophageal Echocardiography (TTE) are the most 
commonly used methods to investigate the cardioembolic 
causes of stroke. However, TEE has been mentioned to 
be better than TTE for finding some speculated causes of 
embolization, such as aortic arch Atheroma, Patent Foramen 
Ovale (PFO), Atrial Septal Aneurysm (ASA), and left atrial 
thrombus (4). Nevertheless, there are still uncertainties 
about the sensitivity, specificity, and cost-effectiveness of 
TTE and/or TEE in detection of cardio-aortic causes of 
stroke (5).
Cost-effectiveness analysis is the most prevalent form of 
economic evaluation in the health sector. Cost-effectiveness 
analysis compares the outcome of two or more therapeutic 
interventions according to their costs and effectiveness. 
Incremental Cost-Effectiveness Ratio (ICER) is defined 
as subtracting the costs of the current intervention from 
the costs of the new intervention divided by subtraction of 
the effectiveness of the current intervention from that of 
the new one. Consequently, different interventions can be 
compared according to the cost per unit of effectiveness. 
Cost-effectiveness analysis can help policymakers to 
optimally use the limited resources in the health sector (6).
Despite paramount importance of medico-economic studies 
in low-to-intermediate income developing countries, there is 
scarce data about the cost-effectiveness of TTE and/or TEE 
in patients with ischemic stroke in these countries. 
2. Objectives
The present study aimed to investigate the cost-
effectiveness of TTE and TEE using a decision analytic 
model in non-selected patients with acute ischemic stroke 
with or without clinical and radiological signs of embolic 
pattern.
3. Patients and Methods
This cross-sectional, cost-effectiveness study was 
conducted in Nemazee hospital affiliated to Shiraz 
University of Medical Sciences from January 2014 to 
April 2014. This hospital is a referral center for stroke in 
Southwestern Iran.
The inclusion criteria of the study were aging above 18 
years, suffering from ischemic stroke defined according 
to the Recognition of Stroke in the Emergency Room 
(ROSIER) scale (7), and signing the informed consent 
form. The included patients had to undergo both TEE and 
TTE on the same day or at most within 7 days in a single 
admission. All patients with ischemic stroke were included 
non-selectively regardless of the presence or absence of the 
above-mentioned clinical and imaging findings indicating a 
cardioembolic source for stroke. Patients with intracranial 
hemorrhage, vasculitis, connective tissue disease, cerebral 
venous thrombosis, aortic dissection, and incomplete 
medical charts were excluded from the study.
According to a previous study (8) and by using the 
following formula assuming p0 = 0.17, p1 = 0.37, α = 0.05, 
and β = 0.8, the sample size was estimated as 65 patients. 
All consecutive patients were recruited.
Two-dimensional transthoracic and color Doppler 
echocardiography were performed using 2.5 MHZ probe. 
Besides, TEE was performed by omniplane probe. The 
procedure was performed without sedation in conscious 
patients. Lidocaine spray was used for local pharyngeal 
anesthesia. TEE was performed according to a standardized 
protocol including adequate visualization of all cardiac 
structures with emphasis on both atria, left atrial appendage, 
interatrial septum, mitral valve apparatus, and thoracic 
aorta. In addition, intravenous sterile isotonic saline was 
administered to assess atrial septal defects. Echo contrast 
with air (9:1 ratio) with a subsequent Valsalva maneuver 
was used to evaluate the right to left shunt. All cardio-aortic 
structures were tried to be adequately visualized. Agitated 
saline test was done for all TEE patients. In so doing, 9 cc 
normal saline was mixed with 0.5 cc of patient’s own blood 
and 0.5 cc air and was injected through a large venous line. 
Echocardiograms were recorded on DVDs.
Two echocardiographers separately evaluated the recorded 
TTEs and TEEs and completed a designated questionnaire 
for each patient. The cardiologists were completely blind 
to the clinical diagnoses, age, sex, and number of patients 
in each diagnostic group. If there was inter-observer 
disagreement, it was settled by ombudsman opinion of a 
third cardiologist who was also blind to clinical diagnoses. 
Left atrial thrombosis, left atrial appendage thrombus, left 
ventricular thrombus, valvular heart disease, bioprosthetic 
or mechanical heart valves, Ejection Fraction (EF) < 28%, 
dilated cardiomyopathy, atrial myxoma, PFO, spontaneous 
echo contrast in the left atrium, spontaneous echo contrast 
in the left ventricle, mobile atheroma in ascending aorta 
and aortic arch, grade 4 atheroma in ascending aorta and 
aortic arch, and aneurysm of inter atrial septum Septum 
were the disorders for which echo was used.
In this study, using decision tree model, the expected 
costs and effectiveness of TEE and TTE were estimated 
and ICER was measured. A decision tree model is a 
systematic quantitative method used for decision-making 
under uncertain conditions in which at least two decision 
options and their respective consequences are evaluated and 
compared in terms of their expected costs and outcomes. 
ICER has been defined as the ratio of the difference between 
the costs of two options to the difference between their 
effectiveness. If ICER is negative, one of the options is 
dominant in comparison to the other. On the other hand, 
if ICER is positive, the maxi¬mum willingness to pay 
(threshold) would be required for decision making (9). Cost-
effectiveness threshold is essentially a level of ICER that 
any intervention should meet if it is to be regarded as a cost-
effective one. In this study, World Health Organization’s 
(WHO) method was used to calculate the threshold. 
Although this recommendation of WHO about threshold 
is mostly used for the cost utility analyses with “cost per 
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QALY gained” or “cost per DALY averted” as outcome, 
because there is not any threshold calculated or accepted for 
Iran, we used it as our threshold. Therefore, if ICER is three 
times lower than the GDP per capita, the studied method 
will be cost-effective. This model can be used to compare 
screening strategies, treatment proposals, and diagnostic 
methods in order to help policymakers and clinicians for 
better decision making (10-12). In addition, to increase the 
accuracy of the study, one-way deterministic sensitivity 
analysis (Tornado diagram) and probabilistic sensitivity 
analysis were performed (13). In the probabilistic sensitivity 
analysis, values for parameters were randomly selected from 
their probability distributions and 95% Confidence Intervals 
(CIs) were calculated using non-parametric bootstrapping 
approach for cost and effectiveness. The non-parametric 
bootstrap is a method for estimating uncertainty using the 
empirical estimation of the sampling distribution. This 
involves re-sampling from the data set with replacement 
while preserving the original structure of the data (e.g. 
same size, same numbers in each treatment group, etc.). 
The advantage of such non-parametric bootstrap CIs is 
that they do not depend on parametric assumptions of the 
sampling distribution of ICER (14).
3.1. The Effectiveness Outcome
In this study, due to lack of a gold standard, the studied 
effectiveness was determined based on the number of 
disorders diagnosed by each of the two echoes confirmed 
by the two cardiologists (true positives).
3.2. Costs
In this study, only the direct costs of TTE and TEE paid 
by the patients were recorded. The data related to the direct 
costs were obtained from the patients’ bills in their charts. 
Therefore, this study was carried out from the patients’ 
perspective. For the purpose of international comparison, 
the costs were converted to US dollar using the exchange 
rate of each US dollar equal to 2510 Rials in 2014 (15). 
Furthermore, as the duration of the study was less than 
one year, the discount rate was not calculated for the costs 
(16). After drawing the decision tree, ICER was calculated. 
As all economic studies are associated with an inherent 
uncertainty, the robustness and generalizability was 
assessed using one-way and probabilistic sensitive analyses 
in this study. In one-way sensitivity analysis, each of the 
study variables were increased by 20% and the results were 
shown by the Tornado diagram. 
This research was approved by the Ethics Committee of 
Shiraz University of Medical Sciences (No. 92-6801) and 
informed consents were obtained from all participants.
3.3. Economic and Statistical Analyses
In this study, Tree Age Pro 2011 was used to analyze 
the collected data and create the related decision tree, 
calculate the cost-effectiveness ratio of using TTEs or 
TEEs in the studied patients, calculate the ICER, perform 
the probabilistic sensitivity analysis, and draw the cost-
effectiveness and Tornado diagrams.
3.4. Ethics of Study
Informed consents were obtained from all participants. 
This research was approved by the Ethics Committee of 
Shiraz University of Medical Sciences (No. 92-6801).
4. Results
This study was performed on 65 patients (51.3% male, 
mean age of 69.7 ± 17.9 years). Among the patients, 9.2%, 
20%, 40%, and 30.8% belonged to 21 - 40, 41 - 60, 61 - 
80, and more than 80 years age groups, respectively. The 
effectiveness of each studied echo has been presented in 
Table 1.
The costs of TTE and TEE for all the patients was 527$ 
(13227700 IRR) and 2021$ (50727100 IRR), respectively. 
The decision tree model related to the costs, effectiveness, 
and probabilities of performing TTE and TEE has been 
shown in Figure 1. As can be seen in this figure, the studied 
patients with stroke were divided into two groups of TEE 
and TTE. Then, the patients were divided into true- and 
false-positive cases. The values below the tree lines 
represent the probabilities and the values at the right hand 
of the tree indicate the values of cost and effectiveness. The 
results of economic evaluation of TEE in comparison to 
TTE showed that performing TEE would increase the costs 
by 1494 USD and the effectiveness by 7%. According to the 
ICER results, for each increment unit in the effectiveness, 
performing TEE would increase the costs by 213.4 USD 
compared to TTE.
The results of analysis of cost-effectiveness of TTE versus 
TEE in different age groups have been depicted in Figure 
2. Accordingly, while TTE was cost-effective in 41-60- 
and 61-80-years age groups, TEE was cost-effective in 
41-60-years age group. However, none of the techniques 
Table 1. The Effectiveness of Each Studied Echo
Studied Echoes Patients’ Age Group (Year) Disorders Diagnosed 
by Echoes
True Positives False Negatives Effectiveness (True Positives/True 
Positives + False Negatives)
TTE 20 - 40 0 0 0 0
41 - 60 15 9 6 0.6
61 - 80 15 13 2 0.86
81 - 100 6 3 3 0.5
Total 36 25 11 0.69
TEE 20 - 40 0 0 0 0
41 - 60 15 15 0 100
61 - 80 15 14 1 0.93
81 - 100 6 5 1 0.83
Total 36 34 2 0.94
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was cost-effective in ages above 81 years. In patients under 
40 years old, cost-effective analysis was not feasible due to 
the small number of true positives.
One-way sensitive analysis using Tornado diagram 
showed that changes in most of the input parameters had 
few effects on the outcome. Moreover, ICER had the highest 
and lowest sensitivities to the increases in the effectiveness 
and costs of TTE, respectively (Figure 3).
The results of probabilistic sensitivity analysis using Monte 
Carlo simulation of incremental costs and effectiveness of 
TEE vs. TTE have been presented in Figure 4. For each 
one of the 10,000 iterations, values for parameters were 
randomly selected from their probability distributions. The 
results showed that TEE was more cost-effective than TTE 
with maximum willingness to pay (threshold) in 97% of 
the iterations.
5. Discussion
In the present study, the researchers investigated the 
cost-effectiveness of transesophgeal and transthoracic 
echocardiographies to detect cardioembolic causes of 
stroke in non-selected patients. ICER for performing TEE 
compared to TTE (213.4 $) was less than three times of 
Iran’s GDP per capita in 2014 (17, 18). It should be mentioned 
that “cost per QALY gained” or “cost per DALY averted” 
should be considered as outcomes in medico-economic 
studies. Since these measures have not been calculated for 
the Iranian population, we considered the cutoff of GDP by 
three for ICER according to WHO’s recommendation (19).
The study results revealed that although considering the 
impact of age, both TTE and TEE were cost-effective in 
the 40-60-years age group, only TTE was cost-effective 
in the 60-80-years age group. In the patients aged more 
than 81 years, neither TTE nor TEE was cost-effective. 
Besides, data were inconclusive for the patients under 40 
years old. These results can be justified by the fact that the 
etiologies responsible for ischemic stroke differ in different 
age groups. The rate of atherosclerotic cardiac diseases and 
dilated cardiomyopathy is higher among patients aged 61-
80 years. Accordingly, TTE would yield more advantages 
over TEE. However, non-atherosclerotic risk factors, such 
as aortic dissection,  PFO, endocarditis, and vulvular heart 
diseases such as rheumatic heart disease are regarded as 
a major cause of Acute Ischemic Stroke (AIS) in patients 
Figure 1. The Decision Tree Model for Comparing TEE to TTE
Figure 2. The Results of Comparison of Cost-Effectiveness of TTE and TEE in Different Age Groups
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aged 41 - 60 years compared to older ones (20). This can 
suggest why TEE infers more benefits in this age group. 
Considering those older than 81 years, the etiologic factors 
responsible for AIS are atrial clots due to atrial fibrillation 
and aortic atheroma (21).
According to de Bruijn et al. (8), TEE is better than TTE 
in detecting the source of emboli in patients with stroke. 
Blum at el. (22) also concluded that in half of the patients 
with stroke, TEE was able to detect a serious lesion not 
detected by TTE. They have suggested that performing 
TEE is crucial in patients with stroke. Similarly, Takeda 
et al. (23) showed that TEE could have more clear results 
in cardiac disorders compared to TTE. The results of the 
study by Cook et al. (24), too, indicated that using TEE in 
surgical ICU is more cost-effective than TTE. However, 
Leung et al. (25) found a very low yield for TEE in 824 
consecutive patients after stroke or other suspected embolic 
events that were in sinus rhythm and had normal TTEs. 
Harloff et al. (26) also found that TEE was unlikely to 
change management in cardioembolic patients as most 
patients already had an indication for oral anticoagulation.
There are some clinical and radiological findings 
indicating more probable cardioembolic sources of stroke. 
They include sudden onset of presentations, absence of 
preceding transient ischemic attack, severe stroke (NIHSS 
> 10 in the elderly, history of ischemic stroke in different 
arterial territories, synchronous new ischemic lesions 
in different arterial territories, metachronous lesions in 
imaging, signs of embolism to other organs (kindney, 
spleen, and/or extremities), presence of territorial (cortical 
plus subcortical) infarct or large lenticulostriate infarction 
in imaging, presence of hyperdense signs in major vessels, 
Figure 3. Tornado Diagram for One-Way Sensitivity Analysis
Figure 4. The Results of the Probabilistic Sensitivity Analysis (Each Point Indicates the Differences in the Costs and Effectiveness 
of TEE vs. TTE)
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and signs of rapid recanalization in transcranial Doppler 
sonographies (4). Thus, performing TTE and TEE in 
selected groups of patients with ischemic stroke and these 
embolic patterns may increase the yield of TTE and TEE.
As no stratification was done based on clinical and 
radiological features indicating embolic phenomenon in 
this study, the results regarding the cost-effectiveness of 
TTE and TEE could be subjected to change if a selected 
group of patients was included. Hence, performing TTE 
and TEE in selected groups of patients with ischemic stroke 
and these embolic patterns may increase the yield of TTE 
and TEE.
There are controversies about major, minor, or uncertain 
contributions of cardioaortic sources of embolic stroke. 
For instance, PFO and aneurysm of the interatrial septum 
which were considered as potential sources of embolism 
in the current study had minor or unclear importance in 
other studies. Furthermore, the current study included 
non-selected population of stroke patients. If the stroke 
patients had been selected according to these criteria, the 
cost-effectiveness results would have been different.
The current study findings were also consistent with some 
studies indicated that TEE could be a useful investigation 
tool in younger patients with ischemic stroke (3, 27).
As both TTE and TEE can be performed simultaneously 
in referral centers in Iran, the results of this study can be 
generalized to other Iranian centers. As to other countries, 
other factors such as selecting the effectiveness index, 
the degree of expenses covered by insurance companies, 
maximum tendency of the government to pay the costs of 
echo methods, and incidence and prevalence of stroke (28) 
should be considered.
One of the limitations of this study was lack of a gold 
standard to determine the effectiveness index. As a result, 
the effectiveness index was determined based on the number 
of diagnoses of each of the two tests confirmed by the two 
cardiologists. In addition, new ultrasound modalities, such 
as second harmonic imaging and Doppler tissue imaging, 
were not used in the current study.
In conclusion, although TEE is cost-effective in general, 
it is mostly recommended in patients aged 41 - 60 years. 
Similar medico-economic studies with larger sample 
sizes and/or in selected patients with higher probability of 
embolic stroke are highly recommended.
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